CAR T-Cells for CNS Lymphoma: Driving into New Terrain?

SIMPLE SUMMARY: Primary or secondary central nervous system (CNS) lymphoma is frequently associated with a poor prognosis. CAR T-cells are being established as a relevant treatment approach in hematological B-cell malignancies. Unfortunately, most clinical studies on chimeric antigen-receptor (CAR)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Karschnia, Philipp, Blobner, Jens, Teske, Nico, Schöberl, Florian, Fitzinger, Esther, Dreyling, Martin, Tonn, Joerg-Christian, Thon, Niklas, Subklewe, Marion, von Baumgarten, Louisa
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8161128/
https://ncbi.nlm.nih.gov/pubmed/34065471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102503
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak